Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Joseph Eron
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Living Beings
Chemicals & Drugs
Procedures
Concepts & Ideas
Anatomy
Physiology
Sign-in to see full Profile
Network (preview)
32
Fiscus, Susan
28
Cohen, Myron
17
Gulick, Roy
16
Kuritzkes, Daniel
14
Napravnik, Sonia
14
Pilcher, Christopher
13
Murphy, Robert
12
Dyer, JR
11
Vernazza, Pietro
10
D'Aquila, Richard
10
Miller, William
8
Kashuba, Angela
8
Gilliam, Bruce
7
McKaig, Rosemary
7
Hammer, Scott
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Joseph Eron (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Deeks Steven G; Gange Stephen J; Kitahata Mari M; Saag Michael S; Justice Amy C; Hogg Robert S; Eron Joseph J; Brooks John T; Rourke Sean B; Gill M John; Bosch Ronald J; Benson Constance A; Collier Ann C; Martin Jeffrey N; Klein Marina B; Jacobson Lisa P; Rodriguez Benigno; Sterling Timothy R; Kirk Gregory D; Napravnik Sonia; Rachlis Anita R; Calzavara Liviana M; Horberg Michael A; Silverberg Michael J; Gebo Kelly A; Kushel Margot B; Goedert James J; McKaig Rosemary G; Moore Richard D
Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;49(10):1582-90.
-
2009: Patterson Kristine B; Cohn Susan E; Uyanik Jennifer; Hughes Michael; Smurzynski Marlene; Eron Joseph J
Treatment responses in antiretroviral treatment-naive premenopausal and postmenopausal HIV-1-infected women: an analysis from AIDS Clinical Trials Group Studies.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;49(3):473-6.
-
2009: Levesque Marc C; Moody M Anthony; Hwang Kwan-Ki; Marshall Dawn J; Whitesides John F; Amos Joshua D; Gurley Thaddeus C; Allgood Sallie; Haynes Benjamin B; Vandergrift Nathan A; Plonk Steven; Parker Daniel C; Cohen Myron S; Tomaras Georgia D; Goepfert Paul A; Shaw George M; Schmitz Jörn E; Eron Joseph J; Shaheen Nicholas J; Hicks Charles B; Liao Hua-Xin; Markowitz Martin; Kelsoe Garnett; Margolis David M; Haynes Barton F
Polyclonal B cell differentiation and loss of gastrointestinal tract germinal centers in the earliest stages of HIV-1 infection.
PLoS medicine 2009;6(7):e1000107.
-
2009: McCoy Sandra I; Eron Joseph J; Kuruc Joann D; Strauss Ronald P; Macdonald Pia D M; Fiscus Susan A; Barnhart John; Pilcher Christopher D; Leone Peter A; Miller William C
Sexually transmitted infections among patients with acute HIV in North Carolina.
Sexually transmitted diseases 2009;36(6):372-4.
-
2009: Eron Joseph J; Park Jeong-Gun; Haubrich Richard; Aweeka Francesca; Bastow Barbara; Pakes Gary E; Yu Song; Wu Hulin; Richman Douglas D;
Predictive value of pharmacokinetics-adjusted phenotypic susceptibility on response to ritonavir-enhanced protease inhibitors (PIs) in human immunodeficiency virus-infected subjects failing prior PI therapy.
Antimicrobial agents and chemotherapy 2009;53(6):2335-41.
-
2009: Ince William L; Harrington Patrick R; Schnell Gretja L; Patel-Chhabra Milloni; Burch Christina L; Menezes Prema; Price Richard W; Eron Joseph J; Swanstrom Ronald I
Major coexisting human immunodeficiency virus type 1 env gene subpopulations in the peripheral blood are produced by cells with similar turnover rates and show little evidence of genetic compartmentalization.
Journal of virology 2009;83(9):4068-80.
-
2009: Westreich Daniel; MacPhail Patrick; Van Rie Annelies; Malope-Kgokong Babatyi; Ive Prudence; Rubel Dennis; Boulmé Ronan; Eron Joseph; Sanne Ian
Effect of pulmonary tuberculosis on mortality in patients receiving HAART.
AIDS (London, England) 2009;23(6):707-15.
-
2009: Hurt Christopher B; McCoy Sandra I; Kuruc Joann; Nelson Julie Ae; Kerkau Melissa; Fiscus Susan; McGee Kara; Sebastian Joseph; Leone Peter; Pilcher Christopher; Hicks Charles; Eron Joseph
Transmitted antiretroviral drug resistance among acute and recent HIV infections in North Carolina from 1998 to 2007.
Antiviral therapy 2009;14(5):673-8.
-
2008: Tomaras Georgia D; Yates Nicole L; Liu Pinghuang; Qin Li; Fouda Genevieve G; Chavez Leslie L; Decamp Allan C; Parks Robert J; Ashley Vicki C; Lucas Judith T; Cohen Myron; Eron Joseph; Hicks Charles B; Liao Hua-Xin; Self Steven G; Landucci Gary; Forthal Donald N; Weinhold Kent J; Keele Brandon F; Hahn Beatrice H; Greenberg Michael L; Morris Lynn; Karim Salim S Abdool; Blattner William A; Montefiori David C; Shaw George M; Perelson Alan S; Haynes Barton F
Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia.
Journal of virology 2008;82(24):12449-63.
-
2008: Petersen Maya L; van der Laan Mark J; Napravnik Sonia; Eron Joseph J; Moore Richard D; Deeks Steven G
Long-term consequences of the delay between virologic failure of highly active antiretroviral therapy and regimen modification.
AIDS (London, England) 2008;22(16):2097-106.
-
2008: Wohl David A; Waters David; Simpson Ross J; Richard Susan; Schnell Amanda; Napravnik Sonia; Keys Jessica; Eron J Joseph; Hsue Priscilla
Ezetimibe alone reduces low-density lipoprotein cholesterol in HIV-infected patients receiving combination antiretroviral therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;47(8):1105-8.
-
2008: Hammer Scott M; Eron Joseph J; Reiss Peter; Schooley Robert T; Thompson Melanie A; Walmsley Sharon; Cahn Pedro; Fischl Margaret A; Gatell Jose M; Hirsch Martin S; Jacobsen Donna M; Montaner Julio S G; Richman Douglas D; Yeni Patrick G; Volberding Paul A;
Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel.
JAMA : the journal of the American Medical Association 2008;300(5):555-70.
-
2008: Archin Nancy M; Eron Joseph J; Palmer Sarah; Hartmann-Duff Anne; Martinson Jeffery A; Wiegand Ann; Bandarenko Nicholas; Schmitz John L; Bosch Ronald J; Landay Alan L; Coffin John M; Margolis David M
Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cells.
AIDS (London, England) 2008;22(10):1131-5.
-
2008: Eron Joseph J
Managing antiretroviral therapy: changing regimens, resistance testing, and the risks from structured treatment interruptions.
The Journal of infectious diseases 2008;197 Suppl 3():S261-71.
-
2008: Gaynes Bradley N; Pence Brian Wells; Eron Joseph J; Miller William C
Prevalence and comorbidity of psychiatric diagnoses based on reference standard in an HIV+ patient population.
Psychosomatic medicine 2008;70(4):505-11.
-
2008: Demeter Lisa M; DeGruttola Victor; Lustgarten Stephanie; Bettendorf Daniel; Fischl Margaret; Eshleman Susan; Spreen William; Nguyen Bach-Yen; Koval Christine E; Eron Joseph J; Hammer Scott; Squires Kathleen
Association of efavirenz hypersusceptibility with virologic response in ACTG 368, a randomized trial of abacavir (ABC) in combination with efavirenz (EFV) and indinavir (IDV) in HIV-infected subjects with prior nucleoside analog experience.
HIV clinical trials 2008;9(1):11-25.
-
2008: Murphy Robert L; da Silva Barbara A; Hicks Charles B; Eron Joseph J; Gulick Roy M; Thompson Melanie A; McMillan Florence; King Martin S; Hanna George J; Brun Scott C
Seven-year efficacy of a lopinavir/ritonavir-based regimen in antiretroviral-naïve HIV-1-infected patients.
HIV clinical trials 2008;9(1):1-10.
-
2008: Murdoch David M; Napravnik Sonia; Eron Joseph J; Van Rie Annelies
Smoking and Predictors of Pneumonia Among HIV-Infected Patients Receiving Care in the HAART Era.
The open respiratory medicine journal 2008;2():22-8.
-
2007: Bakshi Rahul P; Hamzeh Fayez; Frank Ian; Eron Joseph J; Bosch Ronald J; Rosenkranz Susan L; Cramer Yoninah S; Ussery Michael; Flexner Charles
Effect of hydroxyurea and dideoxyinosine on intracellular 3'-deoxyadenosine-5'-triphosphate concentrations in HIV-infected patients.
AIDS research and human retroviruses 2007;23(11):1360-5.
-
2007: Patterson Kristine B; Leone Peter A; Fiscus Susan A; Kuruc Joann; McCoy Sandra I; Wolf Leslie; Foust Evelyn; Williams Del; Eron Joseph J; Pilcher Christopher D
Frequent detection of acute HIV infection in pregnant women.
AIDS (London, England) 2007;21(17):2303-8.
-
2007: Patterson K; Napravnik S; Eron J; Keruly J; Moore R
Effects of age and sex on immunological and virological responses to initial highly active antiretroviral therapy.
HIV medicine 2007;8(6):406-10.
-
2007: Reynes Jacques; Arastéh Keikawus; Clotet Bonaventura; Cohen Calvin; Cooper David A; Delfraissy Jean-François; Eron Joseph J; Henry Keith; Katlama Christine; Kuritzkes Daniel R; Lalezari Jacob P; Lange Joep; Lazzarin Adriano; Montaner Julio S G; Nelson Mark; O' Hearn Mary; Stellbrink Hans-Jürgen; Trottier Benoit; Walmsley Sharon L; Buss Neil E; Demasi Ralph; Chung Jain; Donatacci Lucille; Guimaraes Denise; Rowell Lucy; Valentine Adeline; Wilkinson Martin; Salgo Miklos P
TORO: ninety-six-week virologic and immunologic response and safety evaluation of enfuvirtide with an optimized background of antiretrovirals.
AIDS patient care and STDs 2007;21(8):533-43.
-
2007: Podzamczer Daniel; King Martin S; Klein Cheri E; Flexner Charles; Katlama Christine; Havlir Diane V; Letendre Scott L; Eron Joseph J; Brun Scott C; Bernstein Barry
High-dose lopinavir/ritonavir in highly treatment-experienced HIV-1 patients: efficacy, safety, and predictors of response.
HIV clinical trials 2007;8(4):193-204.
-
2007: Eron Joseph J; Bosch Ronald J; Bettendorf Daniel; Petch Leslie; Fiscus Susan; Frank Ian;
The effect of lamivudine therapy and M184V on the antiretroviral activity of didanosine.
Journal of acquired immune deficiency syndromes (1999) 2007;45(2):249-51.
-
2007: Eron Joseph J
14th annual retrovirus conference (CROI). One-on-one with Joseph J. Eron, MD. Interview by Jeff Berry.
Positively aware : the monthly journal of the Test Positive Aware Network 2007;18(3):31-3.
-
2007: Napravnik Sonia; Keys Jessica R; Quinlivan E Byrd; Wohl David A; Mikeal Oksana V; Eron Joseph J
Triple-class antiretroviral drug resistance: risk and predictors among HIV-1-infected patients.
AIDS (London, England) 2007;21(7):825-34.
-
2007: Gange Stephen J; Kitahata Mari M; Saag Michael S; Bangsberg David R; Bosch Ronald J; Brooks John T; Calzavara Liviana; Deeks Steven G; Eron Joseph J; Gebo Kelly A; Gill M John; Haas David W; Hogg Robert S; Horberg Michael A; Jacobson Lisa P; Justice Amy C; Kirk Gregory D; Klein Marina B; Martin Jeffrey N; McKaig Rosemary G; Rodriguez Benigno; Rourke Sean B; Sterling Timothy R; Freeman Aimee M; Moore Richard D
Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD).
International journal of epidemiology 2007;36(2):294-301.
-
2007: Westreich Daniel; Eron Joseph; Behets Frieda; Horst Charles van der; Van Rie Annelies
Survival in women exposed to single-dose nevirapine for prevention of mother-to-child transmission of HIV: a stochastic model.
The Journal of infectious diseases 2007;195(6):837-46.
-
2007: Landay Alan; da Silva Barbara A; King Martin S; Albrecht Mary; Benson Constance; Eron Joseph; Glesby Marshall; Gulick Roy; Hicks Charles; Kessler Harold; Murphy Robert; Thompson Melanie; White A Clinton; Wolfe Peter; McMillan Florence I; Hanna George J
Evidence of ongoing immune reconstitution in subjects with sustained viral suppression following 6 years of lopinavir-ritonavir treatment.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;44(5):749-54.
-
2007: Pence Brian Wells; Miller William C; Gaynes Bradley N; Eron Joseph J
Psychiatric illness and virologic response in patients initiating highly active antiretroviral therapy.
Journal of acquired immune deficiency syndromes (1999) 2007;44(2):159-66.
-
2007: Moore Jeff D; Acosta Edward P; Johnson Victoria A; Bassett Roland; Eron Joseph J; Fischl Margaret A; Long Mary C; Kuritzkes Daniel R; Sommadossi Jean-Pierre
Intracellular nucleoside triphosphate concentrations in HIV-infected patients on dual nucleoside reverse transcriptase inhibitor therapy.
Antiviral therapy 2007;12(6):981-6.
-
2007: Miles Margaret Shandor; Holditch-Davis Diane; Pedersen Cort; Eron Joseph J; Schwartz Todd
Emotional distress in African American women with HIV.
Journal of prevention & intervention in the community 2007;33(1-2):35-50.
-
2006: Jacobson Jeffrey M; Pat Bucy R; Spritzler John; Saag Michael S; Eron Joseph J; Coombs Robert W; Wang Rui; Fox Lawrence; Johnson Victoria A; Cu-Uvin Susan; Cohn Susan E; Mildvan Donna; O'Neill Dorothy; Janik Jennifer; Purdue Lynette; O'Connor Deborah K; Vita Christine Di; Frank Ian;
Evidence that intermittent structured treatment interruption, but not immunization with ALVAC-HIV vCP1452, promotes host control of HIV replication: the results of AIDS Clinical Trials Group 5068.
The Journal of infectious diseases 2006;194(5):623-32.
-
2006: Eron Joseph; Yeni Patrick; Gathe Joseph; Estrada Vicente; DeJesus Edwin; Staszewski Schlomo; Lackey Philip; Katlama Christine; Young Benjamin; Yau Linda; Sutherland-Phillips Denise; Wannamaker Paul; Vavro Cindy; Patel Lisa; Yeo Jane; Shaefer Mark;
The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial.
Lancet 2006;368(9534):476-82.
-
2006: Corbett Amanda H; Patterson Kristine B; Tien Hsiao-Chuan; Kalvass Leslie A; Eron Joseph J; Ngo Linh T; Lim Michael L; Kashuba Angela D M
Dose separation does not overcome the pharmacokinetic interaction between fosamprenavir and lopinavir/ritonavir.
Antimicrobial agents and chemotherapy 2006;50(8):2756-61.
-
2006: Parsons Thomas D; Tucker Karen A; Hall Colin D; Robertson Wendy T; Eron Joseph J; Fried Michael W; Robertson Kevin R
Neurocognitive functioning and HAART in HIV and hepatitis C virus co-infection.
AIDS (London, England) 2006;20(12):1591-5.
-
2006: Wu Hulin; Huang Yangxin; Acosta Edward P; Park Jeong-Gun; Yu Song; Rosenkranz Susan L; Kuritzkes Daniel R; Eron Joseph J; Perelson Alan S; Gerber John G
Pharmacodynamics of antiretroviral agents in HIV-1 infected patients: using viral dynamic models that incorporate drug susceptibility and adherence.
Journal of pharmacokinetics and pharmacodynamics 2006;33(4):399-419.
-
2006: Franceschini Nora; Napravnik Sonia; Finn William F; Szczech Lynda A; Eron Joseph J
Immunosuppression, hepatitis C infection, and acute renal failure in HIV-infected patients.
Journal of acquired immune deficiency syndromes (1999) 2006;42(3):368-72.
-
2006: Pence Brian Wells; Miller William C; Whetten Kathryn; Eron Joseph J; Gaynes Bradley N
Prevalence of DSM-IV-defined mood, anxiety, and substance use disorders in an HIV clinic in the Southeastern United States.
Journal of acquired immune deficiency syndromes (1999) 2006;42(3):298-306.
-
2006: Lambert Nathan; Mehta Brijesh; Walters Ruth; Eron Joseph J
Chagasic encephalitis as the initial manifestation of AIDS.
Annals of internal medicine 2006;144(12):941-3.
-
2006: Yeh Rosa F; Gaver Vincent E; Patterson Kristine B; Rezk Naser L; Baxter-Meheux Faustina; Blake Michael J; Eron Joseph J; Klein Cheri E; Rublein John C; Kashuba Angela D M
Lopinavir/ritonavir induces the hepatic activity of cytochrome P450 enzymes CYP2C9, CYP2C19, and CYP1A2 but inhibits the hepatic and intestinal activity of CYP3A as measured by a phenotyping drug cocktail in healthy volunteers.
Journal of acquired immune deficiency syndromes (1999) 2006;42(1):52-60.
-
2006: Gay Cynthia L; Napravnik Sonia; Eron Joseph J
Advanced immunosuppression at entry to HIV care in the southeastern United States and associated risk factors.
AIDS (London, England) 2006;20(5):775-8.
-
2006: Hooshyar Dina; Napravnik Sonia; Miller William C; Eron Joseph J
Effect of hepatitis C coinfection on discontinuation and modification of initial HAART in primary HIV care.
AIDS (London, England) 2006;20(4):575-83.
-
2006: Napravnik Sonia; Eron Joseph J; McKaig Rosemary G; Heine Amy D; Menezes Prema; Quinlivan Evelyn
Factors associated with fewer visits for HIV primary care at a tertiary care center in the Southeastern U.S.
AIDS care 2006;18 Suppl 1():S45-50.
-
2006: Whetten K; Reif S; Ostermann J; Pence B W; Swartz M; Whetten R; Conover C; Bouis S; Thielman N; Eron J
Improving health outcomes among individuals with HIV, mental illness, and substance use disorders in the Southeast.
AIDS care 2006;18 Suppl 1():S18-26.
-
2005: Pence Brian Wells; Gaynes Bradley N; Whetten Kathryn; Eron Joseph J; Ryder Robert W; Miller William C
Validation of a brief screening instrument for substance abuse and mental illness in HIV-positive patients.
Journal of acquired immune deficiency syndromes (1999) 2005;40(4):434-44.
-
2005: Nelson Mark; Arastéh Keikawus; Clotet Bonaventura; Cooper David A; Henry Keith; Katlama Christine; Lalezari Jacob P; Lazzarin Adriano; Montaner Julio S G; O'Hearn Mary; Piliero Peter J; Reynes Jacques; Trottier Benoit; Walmsley Sharon L; Cohen Calvin; Eron Joseph J; Kuritzkes Daniel R; Lange Joep; Stellbrink Hans-Jürgen; Delfraissy Jean-François; Buss Neil E; Donatacci Lucille; Wat Cynthia; Smiley Lynn; Wilkinson Martin; Valentine Adeline; Guimaraes Denise; Demasi Ralph; Chung Jain; Salgo Miklos P
Durable efficacy of enfuvirtide over 48 weeks in heavily treatment-experienced HIV-1-infected patients in the T-20 versus optimized background regimen only 1 and 2 clinical trials.
Journal of acquired immune deficiency syndromes (1999) 2005;40(4):404-12.
-
2005: Thompson Melanie A; Kessler Harold A; Eron Joseph J; Jacobson Jeffrey M; Adda Nathalie; Shen Gong; Zong Jian; Harris Jeanette; Moxham Cary; Rousseau Franck S;
Short-term safety and pharmacodynamics of amdoxovir in HIV-infected patients.
AIDS (London, England) 2005;19(15):1607-15.
-
2005: Sempowski Gregory D; Hicks Charles B; Eron Joseph J; Bartlett John A; Hale Laura P; Ferrari Guido; Edwards Lloyd J; Fiscus Susan; Haynes Barton F
Naïve T cells are maintained in the periphery during the first 3 months of acute HIV-1 infection: implications for analysis of thymus function.
Journal of clinical immunology 2005;25(5):462-72.
-
2005: Napravnik Sonia; Edwards David; Stewart Paul; Stalzer Brant; Matteson Elizabeth; Eron Joseph J
HIV-1 drug resistance evolution among patients on potent combination antiretroviral therapy with detectable viremia.
Journal of acquired immune deficiency syndromes (1999) 2005;40(1):34-40.
-
2005: Wu Hulin; Huang Yangxin; Acosta Edward P; Rosenkranz Susan L; Kuritzkes Daniel R; Eron Joseph J; Perelson Alan S; Gerber John G
Modeling long-term HIV dynamics and antiretroviral response: effects of drug potency, pharmacokinetics, adherence, and drug resistance.
Journal of acquired immune deficiency syndromes (1999) 2005;39(3):272-83.
-
2005: Pilcher Christopher D; Fiscus Susan A; Nguyen Trang Q; Foust Evelyn; Wolf Leslie; Williams Del; Ashby Rhonda; O'Dowd Judy Owen; McPherson J Todd; Stalzer Brandt; Hightow Lisa; Miller William C; Eron Joseph J; Cohen Myron S; Leone Peter A
Detection of acute infections during HIV testing in North Carolina.
The New England journal of medicine 2005;352(18):1873-83.
-
2005: Franceschini Nora; Napravnik Sonia; Eron Joseph J; Szczech Lynda A; Finn William F
Incidence and etiology of acute renal failure among ambulatory HIV-infected patients.
Kidney international 2005;67(4):1526-31.
-
2005: Whetten Kathryn; Reif Susan; Swartz Marvin; Stevens Rachel; Ostermann Jan; Hanisch Laura; Eron Joseph J
A brief mental health and substance abuse screener for persons with HIV.
AIDS patient care and STDs 2005;19(2):89-99.
-
2005: Whetten Kathryn; Reif Susan S; Napravnik Sonia; Swartz Marvin S; Thielman Nathan M; Eron Joseph J; Lowe Kristin; Soto Tomas
Substance abuse and symptoms of mental illness among HIV-positive persons in the Southeast.
Southern medical journal 2005;98(1):9-14.
-
2004: Eron Joseph J; Bartlett John A; Santana Jorge L; Bellos Nicholas C; Johnson Judy; Keller Amy; Kuritzkes Daniel R; St Clair Marty H; Johnson Victoria A
Persistent antiretroviral activity of nucleoside analogues after prolonged zidovudine and lamivudine therapy as demonstrated by rapid loss of activity after discontinuation.
Journal of acquired immune deficiency syndromes (1999) 2004;37(5):1581-3.
-
2004: Acosta Edward P; Wu Hulin; Hammer Scott M; Yu Song; Kuritzkes Daniel R; Walawander Ann; Eron Joseph J; Fichtenbaum Carl J; Pettinelli Carla; Neath Denise; Ferguson Elaine; Saah Alfred J; Gerber John G;
Comparison of two indinavir/ritonavir regimens in the treatment of HIV-infected individuals.
Journal of acquired immune deficiency syndromes (1999) 2004;37(3):1358-66.
-
2004: Ritola Kimberly; Pilcher Christopher D; Fiscus Susan A; Hoffman Noah G; Nelson Julie A E; Kitrinos Kathryn M; Hicks Charles B; Eron Joseph J; Swanstrom Ronald
Multiple V1/V2 env variants are frequently present during primary infection with human immunodeficiency virus type 1.
Journal of virology 2004;78(20):11208-18.
-
2004: Frank Ian; Bosch Ronald J; Fiscus Susan; Valentine Fred; Flexner Charles; Segal Yoninah; Ruan Ping; Gulick Roy; Wood Kenneth; Estep Scharla; Fox Lawrence; Nevin Thomas; Stevens Michael; Eron Joseph J;
Activity, safety, and immunological effects of hydroxyurea added to didanosine in antiretroviral-naive and experienced HIV type 1-infected subjects: a randomized, placebo-controlled trial, ACTG 307.
AIDS research and human retroviruses 2004;20(9):916-26.
-
2004: Wood Robin; Eron Joseph; Arasteh Keikawus; Teofilo Eugenio; Trepo Christian; Livrozet Jean-Michel; Yeo Jane; Millard Judith; Wire Mary Beth; Naderer Odin J
A 42-week open-label study to assess the pharmacokinetics, antiretroviral activity, and safety of amprenavir or amprenavir plus ritonavir in combination with abacavir and lamivudine for treatment of HIV-infected patients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(4):591-4.
-
2004: Lim Michael L; Min Sherene S; Eron Joseph J; Bertz Richard J; Robinson Marjorie; Gaedigk Andrea; Kashuba Angela D M
Coadministration of lopinavir/ritonavir and phenytoin results in two-way drug interaction through cytochrome P-450 induction.
Journal of acquired immune deficiency syndromes (1999) 2004;36(5):1034-40.
-
2004: Corbett Amanda H; Eron Joseph J; Fiscus Susan A; Rezk Naser L; Kashuba Angela D M
The pharmacokinetics, safety, and initial virologic response of a triple-protease inhibitor salvage regimen containing amprenavir, saquinavir, and ritonavir.
Journal of acquired immune deficiency syndromes (1999) 2004;36(4):921-8.
-
2004: Tapper Michael L; Flexner Charles; Eron Joseph J; Molina Jean-Michael
Simplifying antiretroviral therapy.
The AIDS reader 2004;14(7):355-60, 367-71.
-
2004: Pilcher Christopher D; Tien Hsiao Chuan; Eron Joseph J; Vernazza Pietro L; Leu Szu-Yun; Stewart Paul W; Goh Li-Ean; Cohen Myron S;
Brief but efficient: acute HIV infection and the sexual transmission of HIV.
The Journal of infectious diseases 2004;189(10):1785-92.
-
2004: Conradie Francesca; Sanne Ian; Venter Willem; Eron Joseph
Failure of lopinavir-ritonavir (Kaletra)-containing regimen in an antiretroviral-naive patient.
AIDS (London, England) 2004;18(7):1084-5.
-
2004: Pilcher Christopher D; Eron Joseph J; Galvin Shannon; Gay Cynthia; Cohen Myron S
Acute HIV revisited: new opportunities for treatment and prevention.
The Journal of clinical investigation 2004;113(7):937-45.
-
2004: Hicks Charles; King Martin S; Gulick Roy M; White A Clinton; Eron Joseph J; Kessler Harold A; Benson Constance; King Kathryn R; Murphy Robert L; Brun Scott C
Long-term safety and durable antiretroviral activity of lopinavir/ritonavir in treatment-naive patients: 4 year follow-up study.
AIDS (London, England) 2004;18(5):775-9.
-
2004: Eron Joseph J; Gulick Roy M; Bartlett John A; Merigan Thomas; Arduino Roberto; Kilby J Michael; Yangco Bienvenido; Diers Adriann; Drobnes Claude; DeMasi Ralph; Greenberg Michael; Melby Thomas; Raskino Claire; Rusnak Pam; Zhang Ying; Spence Rebecca; Miralles G Diego
Short-term safety and antiretroviral activity of T-1249, a second-generation fusion inhibitor of HIV.
The Journal of infectious diseases 2004;189(6):1075-83.
-
2004: Pilcher Christopher D; Price Matthew A; Hoffman Irving F; Galvin Shannon; Martinson Francis E A; Kazembe Peter N; Eron Joseph J; Miller William C; Fiscus Susan A; Cohen Myron S
Frequent detection of acute primary HIV infection in men in Malawi.
AIDS (London, England) 2004;18(3):517-24.
-
2004: Al-Harthi L; Voris J; Patterson B K; Becker S; Eron J; Smith K Y; D'Amico R; Mildvan D; Snidow J; Pobiner B; Yau L; Landay A
Evaluation of the impact of highly active antiretroviral therapy on immune recovery in antiretroviral naive patients.
HIV medicine 2004;5(1):55-65.
-
2004: Eron Joseph J; Feinberg Judith; Kessler Harold A; Horowitz Harold W; Witt Mallory D; Carpio Felix F; Wheeler David A; Ruane Peter; Mildvan Donna; Yangco Bienvenido G; Bertz Richard; Bernstein Barry; King Martin S; Sun Eugene
Once-daily versus twice-daily lopinavir/ritonavir in antiretroviral-naive HIV-positive patients: a 48-week randomized clinical trial.
The Journal of infectious diseases 2004;189(2):265-72.
-
2004: Wood Robin; Arasteh Keikawus; Stellbrink Hans-Jürgen; Teofilo Eugenio; Raffi François; Pollard Richard B; Eron Joseph; Yeo Jane; Millard Judith; Wire Mary Beth; Naderer Odin J
Six-week randomized controlled trial to compare the tolerabilities, pharmacokinetics, and antiviral activities of GW433908 and amprenavir in human immunodeficiency virus type 1-infected patients.
Antimicrobial agents and chemotherapy 2004;48(1):116-23.
-
2003: Hammer Scott M; Bassett Roland; Squires Kathleen E; Fischl Margaret A; Demeter Lisa M; Currier Judith S; Mellors John W; Morse Gene D; Eron Joseph J; Santana Jorge L; DeGruttola Victor;
A randomized trial of nelfinavir and abacavir in combination with efavirenz and adefovir dipivoxil in HIV-1-infected persons with virological failure receiving indinavir.
Antiviral therapy 2003;8(6):507-18.
-
2003: Miles Margaret Shandor; Holditch-Davis Diane; Eron Joseph; Black Beth Perry; Pedersen Cort; Harris Donna A
An HIV self-care symptom management intervention for African American mothers.
Nursing research 2003;52(6):350-60.
-
2003: Gulick Roy M; Meibohm Anne; Havlir Diane; Eron Joseph J; Mosley Audrey; Chodakewitz Jeffrey A; Isaacs Robin; Gonzalez Charles; McMahon Deborah; Richman Douglas D; Robertson Michael; Mellors John W
Six-year follow-up of HIV-1-infected adults in a clinical trial of antiretroviral therapy with indinavir, zidovudine, and lamivudine.
AIDS (London, England) 2003;17(16):2345-9.
-
2003: Weintrob Amy C; Giner Julieta; Menezes Prema; Patrick Ericka; Benjamin Daniel Kelly; Lennox Jeffrey; Pilcher Christopher D; Eron Joseph J; Hicks Charles B
Infrequent diagnosis of primary human immunodeficiency virus infection: missed opportunities in acute care settings.
Archives of internal medicine 2003;163(17):2097-100.
-
2003: Freel Stephanie A; Fiscus Susan A; Pilcher Christopher D; Menezes Prema; Giner Julieta; Patrick Ericka; Lennox Jeffrey L; Hicks Charles B; Eron Joseph J; Shugars Diane C
Envelope diversity, coreceptor usage and syncytium-inducing phenotype of HIV-1 variants in saliva and blood during primary infection.
AIDS (London, England) 2003;17(14):2025-33.
-
2003: Fischl Margaret A; Ribaudo Heather J; Collier Ann C; Erice Alejo; Giuliano Marina; Dehlinger Marjorie; Eron Joseph J; Saag Michael S; Hammer Scott M; Vella Stefano; Morse Gene D; Feinberg Judith E; Demeter Lisa M; Eshleman Susan H;
A randomized trial of 2 different 4-drug antiretroviral regimens versus a 3-drug regimen, in advanced human immunodeficiency virus disease.
The Journal of infectious diseases 2003;188(5):625-34.
-
2003: Kilby J Michael; Eron Joseph J
Novel therapies based on mechanisms of HIV-1 cell entry.
The New England journal of medicine 2003;348(22):2228-38.
-
2003: Lalezari Jacob P; Henry Keith; O'Hearn Mary; Montaner Julio S G; Piliero Peter J; Trottier Benôit; Walmsley Sharon; Cohen Calvin; Kuritzkes Daniel R; Eron Joseph J; Chung Jain; DeMasi Ralph; Donatacci Lucille; Drobnes Claude; Delehanty John; Salgo Miklos;
Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America.
The New England journal of medicine 2003;348(22):2175-85.
-
2003: Lalezari Jacob P; Eron Joseph J; Carlson Margrit; Cohen Calvin; DeJesus Edwin; Arduino Roberto C; Gallant Joel E; Volberding Paul; Murphy Robert L; Valentine Fred; Nelson Emily L; Sista Prakash R; Dusek Alex; Kilby J Michael
A phase II clinical study of the long-term safety and antiviral activity of enfuvirtide-based antiretroviral therapy.
AIDS (London, England) 2003;17(5):691-8.
-
2003: Patton Lauren L; Strauss Ronald P; McKaig Rosemary G; Porter Dawn R; Eron Joseph J
Perceived oral health status, unmet needs, and barriers to dental care among HIV/AIDS patients in a North Carolina cohort: impacts of race.
Journal of public health dentistry 2003;63(2):86-91.
-
2002: Kirk Ole; Pedersen Court; Law Matthew; Gulick Roy M; Moyle Graeme; Montaner Julio; Eron Joseph J; Phillips Andrew N; Lundgren Jens D
Analysis of virological efficacy in trials of antiretroviral regimens: drawbacks of not including viral load measurements after premature discontinuation of therapy.
Antiviral therapy 2002;7(4):271-81.
-
2002: Reddy Y Sunila; Gotzkowsky S Karl; Eron Joseph J; Kim Julie Y; Fiske William D; Fiscus Susan A; Petch Leslie; Cohen Myron S; Kashuba Angela D M
Pharmacokinetic and pharmacodynamic investigation of efavirenz in the semen and blood of human immunodeficiency virus type 1-infected men.
The Journal of infectious diseases 2002;186(9):1339-43.
-
2002: Napravnik Sonia; Poole Charles; Thomas James C; Eron Joseph J
Gender difference in HIV RNA levels: a meta-analysis of published studies.
Journal of acquired immune deficiency syndromes (1999) 2002;31(1):11-9.
-
2002: Chaudry Naumann I; Eron Joseph J; Naderer Odin J; Pereira Arlene S; Wire M B; Fiscus Susan A; Kashuba Angela D M
Effects of formulation and dosing strategy on amprenavir concentrations in the seminal plasma of human immunodeficiency virus type 1-infected men.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;35(6):760-2.
-
2002: Kilby J Michael; Lalezari Jacob P; Eron Joseph J; Carlson Margrit; Cohen Calvin; Arduino Roberto C; Goodgame Jeffrey C; Gallant Joel E; Volberding Paul; Murphy Robert L; Valentine Fred; Saag Michael S; Nelson Emily L; Sista Prakash R; Dusek Alex
The safety, plasma pharmacokinetics, and antiviral activity of subcutaneous enfuvirtide (T-20), a peptide inhibitor of gp41-mediated virus fusion, in HIV-infected adults.
AIDS research and human retroviruses 2002;18(10):685-93.
-
2002: Pereira Arlene S; Smeaton Laura M; Gerber John G; Acosta Edward P; Snyder Sally; Fiscus Susan A; Tidwell Richard R; Gulick Roy M; Murphy Robert L; Eron Joseph J
The pharmacokinetics of amprenavir, zidovudine, and lamivudine in the genital tracts of men infected with human immunodeficiency virus type 1 (AIDS clinical trials group study 850).
The Journal of infectious diseases 2002;186(2):198-204.
-
2002: Pilcher Christopher D; McPherson J Todd; Leone Peter A; Smurzynski Marlene; Owen-O'Dowd Judy; Peace-Brewer Amy L; Harris Juanita; Hicks Charles B; Eron Joseph J; Fiscus Susan A
Real-time, universal screening for acute HIV infection in a routine HIV counseling and testing population.
JAMA : the journal of the American Medical Association 2002;288(2):216-21.
-
2002: Hammer Scott M; Vaida Florin; Bennett Kara K; Holohan Mary K; Sheiner Lewis; Eron Joseph J; Wheat Lawrence Joseph; Mitsuyasu Ronald T; Gulick Roy M; Valentine Fred T; Aberg Judith A; Rogers Michael D; Karol Cheryl N; Saah Alfred J; Lewis Ronald H; Bessen Laura J; Brosgart Carol; DeGruttola Victor; Mellors John W;
Dual vs single protease inhibitor therapy following antiretroviral treatment failure: a randomized trial.
JAMA : the journal of the American Medical Association 2002;288(2):169-80.
-
2002: Benson Constance A; Deeks Steven G; Brun Scott C; Gulick Roy M; Eron Joseph J; Kessler Harold A; Murphy Robert L; Hicks Charles; King Martin; Wheeler David; Feinberg Judith; Stryker Richard; Sax Paul E; Riddler Sharon; Thompson Melanie; Real Kathryn; Hsu Ann; Kempf Dale; Japour Anthony J; Sun Eugene
Safety and antiviral activity at 48 weeks of lopinavir/ritonavir plus nevirapine and 2 nucleoside reverse-transcriptase inhibitors in human immunodeficiency virus type 1-infected protease inhibitor-experienced patients.
The Journal of infectious diseases 2002;185(5):599-607.
-
2002: Garba Mohammed L; Pilcher Christopher D; Bingham Andrea L; Eron Joseph; Frelinger Jeffrey A
HIV antigens can induce TGF-beta(1)-producing immunoregulatory CD8+ T cells.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(5):2247-54.
-
2002: Eron Joseph J
Expert offers help for PI-related heart disease.
AIDS alert 2002;17(2):26-7, 14.
-
2002: Pereira Arlene S; Kenney Kathryn B; Cohen Myron S; Eron Joseph J; Tidwell Richard R; Dunn John A
Determination of amprenavir, a HIV-1 protease inhibitor, in human seminal plasma using high-performance liquid chromatography-tandem mass spectrometry.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2002;766(2):307-17.
-
2001: Albrecht M A; Bosch R J; Hammer S M; Liou S H; Kessler H; Para M F; Eron J; Valdez H; Dehlinger M; Katzenstein D A;
Nelfinavir, efavirenz, or both after the failure of nucleoside treatment of HIV infection.
The New England journal of medicine 2001;345(6):398-407.
-
2001: DeMasi R A; Graham N M; Tolson J M; Pham S V; Capuano G A; Fisher R L; Shaefer M S; Pakes G E; Sawyerr G A; Eron J J
Correlation between self-reported adherence to highly active antiretroviral therapy (HAART) and virologic outcome.
Advances in therapy 2001;18(4):163-73.
-
2001: Pilcher C D; Shugars D C; Fiscus S A; Miller W C; Menezes P; Giner J; Dean B; Robertson K; Hart C E; Lennox J L; Eron J J; Hicks C B
HIV in body fluids during primary HIV infection: implications for pathogenesis, treatment and public health.
AIDS (London, England) 2001;15(7):837-45.
-
2001: Günthard H F; Havlir D V; Fiscus S; Zhang Z Q; Eron J; Mellors J; Gulick R; Frost S D; Brown A J; Schleif W; Valentine F; Jonas L; Meibohm A; Ignacio C C; Isaacs R; Gamagami R; Emini E; Haase A; Richman D D; Wong J K
Residual human immunodeficiency virus (HIV) Type 1 RNA and DNA in lymph nodes and HIV RNA in genital secretions and in cerebrospinal fluid after suppression of viremia for 2 years.
The Journal of infectious diseases 2001;183(9):1318-27.
-
2001: Eron J J; Haubrich R; Lang W; Pagano G; Millard J; Wolfram J; Snowden W; Pedneault L; Tisdale M
A phase II trial of dual protease inhibitor therapy: amprenavir in combination with indinavir, nelfinavir, or saquinavir.
Journal of acquired immune deficiency syndromes (1999) 2001;26(5):458-61.
-
2001: Chakraborty H; Sen P K; Helms R W; Vernazza P L; Fiscus S A; Eron J J; Patterson B K; Coombs R W; Krieger J N; Cohen M S
Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model.
AIDS (London, England) 2001;15(5):621-7.
-
2001: Gulick R M; Smeaton L M; D'Aquila R T; Eron J J; Currier J S; Gerber J G; Acosta E; Sommadossi J P; Tung R; Snyder S; Kuritzkes D R; Murphy R L;
Indinavir, nevirapine, stavudine, and lamivudine for human immunodeficiency virus-infected, amprenavir-experienced subjects: AIDS Clinical Trials Group protocol 373.
The Journal of infectious diseases 2001;183(5):715-21.
-
2001: Shugars D C; Patton L L; Freel S A; Gray L R; Vollmer R T; Eron J J; Fiscus S A
Hyper-excretion of human immunodeficiency virus type 1 RNA in saliva.
Journal of dental research 2001;80(2):414-20.
-
2001: Murphy R L; Brun S; Hicks C; Eron J J; Gulick R; King M; White A C; Benson C; Thompson M; Kessler H A; Hammer S; Bertz R; Hsu A; Japour A; Sun E
ABT-378/ritonavir plus stavudine and lamivudine for the treatment of antiretroviral-naive adults with HIV-1 infection: 48-week results.
AIDS (London, England) 2001;15(1):F1-9.
-
2001: Eron J J; Vernazza P
Alternative strategies for anti-HIV treatment.
AIDS (London, England) 2001;15 Suppl 5():S161-9.
-
2000: Ping L H; Cohen M S; Hoffman I; Vernazza P; Seillier-Moiseiwitsch F; Chakraborty H; Kazembe P; Zimba D; Maida M; Fiscus S A; Eron J J; Swanstrom R; Nelson J A
Effects of genital tract inflammation on human immunodeficiency virus type 1 V3 populations in blood and semen.
Journal of virology 2000;74(19):8946-52.
-
2000: Eron J J; Murphy R L; Peterson D; Pottage J; Parenti D M; Jemsek J; Swindells S; Sepulveda G; Bellos N; Rashbaum B C; Esinhart J; Schoellkopf N; Grosso R; Stevens M
A comparison of stavudine, didanosine and indinavir with zidovudine, lamivudine and indinavir for the initial treatment of HIV-1 infected individuals: selection of thymidine analog regimen therapy (START II).
AIDS (London, England) 2000;14(11):1601-10.
-
2000: Kuritzkes D R; Bassett R L; Johnson V A; Marschner I C; Eron J J; Sommadossi J P; Acosta E P; Murphy R L; Fife K; Wood K; Bell D; Martinez A; Pettinelli C B
Continued lamivudine versus delavirdine in combination with indinavir and zidovudine or stavudine in lamivudine-experienced patients: results of Adult AIDS Clinical Trials Group protocol 370.
AIDS (London, England) 2000;14(11):1553-61.
-
2000: Gulick R M; Mellors J W; Havlir D; Eron J J; Meibohm A; Condra J H; Valentine F T; McMahon D; Gonzalez C; Jonas L; Emini E A; Chodakewitz J A; Isaacs R; Richman D D
3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudine.
Annals of internal medicine 2000;133(1):35-9.
-
2000: Eron J J
HIV-1 protease inhibitors.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;30 Suppl 2():S160-70.
-
2000: Pereira A S; Kenney K B; Cohen M S; Hall J E; Eron J J; Tidwell R R; Dunn J A
Simultaneous determination of lamivudine and zidovudine concentrations in human seminal plasma using high-performance liquid chromatography and tandem mass spectrometry.
Journal of chromatography. B, Biomedical sciences and applications 2000;742(1):173-83.
-
2000: Eron J J; Smeaton L M; Fiscus S A; Gulick R M; Currier J S; Lennox J L; D'Aquila R T; Rogers M D; Tung R; Murphy R L
The effects of protease inhibitor therapy on human immunodeficiency virus type 1 levels in semen (AIDS clinical trials group protocol 850).
The Journal of infectious diseases 2000;181(5):1622-8.
-
2000: Eron J J; Yetzer E S; Ruane P J; Becker S; Sawyer G A; Fisher R L; Tolson J M; Shaefer M S
Efficacy, safety, and adherence with a twice-daily combination lamivudine/zidovudine tablet formulation, plus a protease inhibitor, in HIV infection.
AIDS (London, England) 2000;14(6):671-81.
-
2000: Patton L L; McKaig R; Strauss R; Rogers D; Eron J J
Changing prevalence of oral manifestations of human immuno-deficiency virus in the era of protease inhibitor therapy.
Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 2000;89(3):299-304.
-
2000: Vernazza P L; Troiani L; Flepp M J; Cone R W; Schock J; Roth F; Boggian K; Cohen M S; Fiscus S A; Eron J J
Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV. The Swiss HIV Cohort Study.
AIDS (London, England) 2000;14(2):117-21.
-
2000: Kuritzkes D R; Shugarts D; Bakhtiari M; Poticha D; Johnson J; Rubin M; Gingeras T R; Kennedy M; Eron J J
Emergence of dual resistance to zidovudine and lamivudine in HIV-1-infected patients treated with zidovudine plus lamivudine as initial therapy.
Journal of acquired immune deficiency syndromes (1999) 2000;23(1):26-34.
-
1999: Moore K H; Yuen G J; Hussey E K; Pakes G E; Eron J J; Bartlett J A
Population pharmacokinetics of lamivudine in adult human immunodeficiency virus-infected patients enrolled in two phase III clinical trials.
Antimicrobial agents and chemotherapy 1999;43(12):3025-9.
-
1999: Pereira A S; Kashuba A D; Fiscus S A; Hall J E; Tidwell R R; Troiani L; Dunn J A; Eron J J; Cohen M S
Nucleoside analogues achieve high concentrations in seminal plasma: relationship between drug concentration and virus burden.
The Journal of infectious diseases 1999;180(6):2039-43.
-
1999: Patton L L; McKaig R G; Eron J J; Lawrence H P; Strauss R P
Oral hairy leukoplakia and oral candidiasis as predictors of HIV viral load.
AIDS (London, England) 1999;13(15):2174-6.
-
1999: Pilcher C D; Eron J J; Ngo L; Dusek A; Sista P; Gleavy J; Brooks D; Venetta T; DiMassimo E; Hopkins S
Prolonged therapy with the fusion inhibitor T-20 in combination with oral antiretroviral agents in an HIV-infected individual.
AIDS (London, England) 1999;13(15):2171-3.
-
1999: Rublein J C; Eron J J; Butts J D; Raasch R H
Discontinuation rates for protease inhibitor regimens containing ritonavir 600 mg versus ritonavir 400 mg plus saquinavir 400 mg.
The Annals of pharmacotherapy 1999;33(9):899-905.
-
1999: Betts M R; Krowka J F; Kepler T B; Davidian M; Christopherson C; Kwok S; Louie L; Eron J; Sheppard H; Frelinger J A
Human immunodeficiency virus type 1-specific cytotoxic T lymphocyte activity is inversely correlated with HIV type 1 viral load in HIV type 1-infected long-term survivors.
AIDS research and human retroviruses 1999;15(13):1219-28.
-
1999: Kashuba A D; Dyer J R; Kramer L M; Raasch R H; Eron J J; Cohen M S
Antiretroviral-drug concentrations in semen: implications for sexual transmission of human immunodeficiency virus type 1.
Antimicrobial agents and chemotherapy 1999;43(8):1817-26.
-
1999: Ping L H; Nelson J A; Hoffman I F; Schock J; Lamers S L; Goodman M; Vernazza P; Kazembe P; Maida M; Zimba D; Goodenow M M; Eron J J; Fiscus S A; Cohen M S; Swanstrom R
Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: underrepresentation of X4 variants.
Journal of virology 1999;73(8):6271-81.
-
1999: Pilcher C D; Miller W C; Beatty Z A; Eron J J
Detectable HIV-1 RNA at levels below quantifiable limits by amplicor HIV-1 monitor is associated with virologic relapse on antiretroviral therapy.
AIDS (London, England) 1999;13(11):1337-42.
-
1999: Dyer J R; Hoffman I F; Eron J J; Fiscus S A; Cohen M S
Immune activation and plasma viral load in HIV-infected African individuals.
AIDS (London, England) 1999;13(10):1283-5.
-
1999: Pilcher C D; Perkins M D; Fiscus S A; Johnston D M; Dietze R; Duque U H; Zago A M; Assad-Antunes F; Eron J J
Genotypic resistance and the treatment of HIV-1 infection in Espírito Santo, Brazil.
The Journal of infectious diseases 1999;179(5):1259-63.
-
1999: Kuritzkes D R; Marschner I; Johnson V A; Bassett R; Eron J J; Fischl M A; Murphy R L; Fife K; Maenza J; Rosandich M E; Bell D; Wood K; Sommadossi J P; Pettinelli C
Lamivudine in combination with zidovudine, stavudine, or didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group Protocol 306 Investigators.
AIDS (London, England) 1999;13(6):685-94.
-
1999: Murphy R L; Gulick R M; DeGruttola V; D'Aquila R T; Eron J J; Sommadossi J P; Currier J S; Smeaton L; Frank I; Caliendo A M; Gerber J G; Tung R; Kuritzkes D R
Treatment with amprenavir alone or amprenavir with zidovudine and lamivudine in adults with human immunodeficiency virus infection. AIDS Clinical Trials Group 347 Study Team.
The Journal of infectious diseases 1999;179(4):808-16.
-
1999: Hoffman I F; Jere C S; Taylor T E; Munthali P; Dyer J R; Wirima J J; Rogerson S J; Kumwenda N; Eron J J; Fiscus S A; Chakraborty H; Taha T E; Cohen M S; Molyneux M E
The effect of Plasmodium falciparum malaria on HIV-1 RNA blood plasma concentration.
AIDS (London, England) 1999;13(4):487-94.
-
1999: Vernazza P L; Eron J J; Fiscus S A; Cohen M S
Sexual transmission of HIV: infectiousness and prevention.
AIDS (London, England) 1999;13(2):155-66.
-
1999: Dyer J R; Pilcher C D; Shepard R; Schock J; Eron J J; Fiscus S A
Comparison of NucliSens and Roche Monitor assays for quantitation of levels of human immunodeficiency virus type 1 RNA in plasma.
Journal of clinical microbiology 1999;37(2):447-9.
-
1998: Eron J J; Vernazza P L; Johnston D M; Seillier-Moiseiwitsch F; Alcorn T M; Fiscus S A; Cohen M S
Resistance of HIV-1 to antiretroviral agents in blood and seminal plasma: implications for transmission.
AIDS (London, England) 1998;12(15):F181-9.
-
1998: Patton L L; McKaig R G; Strauss R P; Eron J J
Oral manifestations of HIV in a southeast USA population.
Oral diseases 1998;4(3):164-9.
-
1998: Gulick R M; Mellors J W; Havlir D; Eron J J; Gonzalez C; McMahon D; Jonas L; Meibohm A; Holder D; Schleif W A; Condra J H; Emini E A; Isaacs R; Chodakewitz J A; Richman D D
Simultaneous vs sequential initiation of therapy with indinavir, zidovudine, and lamivudine for HIV-1 infection: 100-week follow-up.
JAMA : the journal of the American Medical Association 1998;280(1):35-41.
-
1998: Dyer J R; Kazembe P; Vernazza P L; Gilliam B L; Maida M; Zimba D; Hoffman I F; Royce R A; Schock J L; Fiscus S A; Cohen M S; Eron J J
High levels of human immunodeficiency virus type 1 in blood and semen of seropositive men in sub-Saharan Africa.
The Journal of infectious diseases 1998;177(6):1742-6.
-
1998: Fiscus S A; Vernazza P L; Gilliam B; Dyer J; Eron J J; Cohen M S
Factors associated with changes in HIV shedding in semen.
AIDS research and human retroviruses 1998;14 Suppl 1():S27-31.
-
1998: Dyer J R; Eron J J; Hoffman I F; Kazembe P; Vernazza P L; Nkata E; Costello Daly C; Fiscus S A; Cohen M S
Association of CD4 cell depletion and elevated blood and seminal plasma human immunodeficiency virus type 1 (HIV-1) RNA concentrations with genital ulcer disease in HIV-1-infected men in Malawi.
The Journal of infectious diseases 1998;177(1):224-7.
-
1997: Gulick R M; Mellors J W; Havlir D; Eron J J; Gonzalez C; McMahon D; Richman D D; Valentine F T; Jonas L; Meibohm A; Emini E A; Chodakewitz J A
Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy.
The New England journal of medicine 1997;337(11):734-9.
-
1997: Hammer S M; Squires K E; Hughes M D; Grimes J M; Demeter L M; Currier J S; Eron J J; Feinberg J E; Balfour H H; Deyton L R; Chodakewitz J A; Fischl M A
A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.
The New England journal of medicine 1997;337(11):725-33.
-
1997: Vernazza P L; Gilliam B L; Flepp M; Dyer J R; Frank A C; Fiscus S A; Cohen M S; Eron J J
Effect of antiviral treatment on the shedding of HIV-1 in semen.
AIDS (London, England) 1997;11(10):1249-54.
-
1997: Vernazza P L; Dyer J R; Fiscus S A; Eron J J; Cohen M S
HIV-1 viral load in blood, semen and saliva.
AIDS (London, England) 1997;11(8):1058-9.
-
1997: Vernazza P L; Gilliam B L; Dyer J; Fiscus S A; Eron J J; Frank A C; Cohen M S
Quantification of HIV in semen: correlation with antiviral treatment and immune status.
AIDS (London, England) 1997;11(8):987-93.
-
1997: Cohen M S; Hoffman I F; Royce R A; Kazembe P; Dyer J R; Daly C C; Zimba D; Vernazza P L; Maida M; Fiscus S A; Eron J J
Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group.
Lancet 1997;349(9069):1868-73.
-
1997: Gilliam B L; Dyer J R; Fiscus S A; Marcus C; Zhou S; Wathen L; Freimuth W W; Cohen M S; Eron J J
Effects of reverse transcriptase inhibitor therapy on the HIV-1 viral burden in semen.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1997;15(1):54-60.
-
1997: Dyer J R; Gilliam B L; Eron J J; Cohen M S; Fiscus S A; Vernazza P L
Shedding of HIV-1 in semen during primary infection.
AIDS (London, England) 1997;11(4):543-5.
-
1997: Vernazza P L; Eron J J
Probability of heterosexual transmission of HIV.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1997;14(1):85-6.
-
1996: Kuritzkes D R; Quinn J B; Benoit S L; Shugarts D L; Griffin A; Bakhtiari M; Poticha D; Eron J J; Fallon M A; Rubin M
Drug resistance and virologic response in NUCA 3001, a randomized trial of lamivudine (3TC) versus zidovudine (ZDV) versus ZDV plus 3TC in previously untreated patients.
AIDS (London, England) 1996;10(9):975-81.
-
1996: Dyer J R; Gilliam B L; Eron J J; Grosso L; Cohen M S; Fiscus S A
Quantitation of human immunodeficiency virus type 1 RNA in cell free seminal plasma: comparison of NASBA with Amplicor reverse transcription-PCR amplification and correlation with quantitative culture.
Journal of virological methods 1996;60(2):161-70.
-
1996: Phillips A N; Eron J J; Bartlett J A; Rubin M; Johnson J; Price S; Self P; Hill A M
HIV-1 RNA levels and the development of clinical disease. North American Lamivudine HIV Working Group.
AIDS (London, England) 1996;10(8):859-65.
-
1996: Moore K H; Yuen G J; Raasch R H; Eron J J; Martin D; Mydlow P K; Hussey E K
Pharmacokinetics of lamivudine administered alone and with trimethoprim-sulfamethoxazole.
Clinical pharmacology and therapeutics 1996;59(5):550-8.
-
1996: Fiscus S A; Royce R; Eron J J
Quality control of HIV cultures in a clinical retrovirology laboratory.
Journal of virological methods 1996;58(1-2):91-8.
-
1996: Vernazza P L; Eron J J; Fiscus S A
Sensitive method for the detection of infectious HIV in semen of seropositive individuals.
Journal of virological methods 1996;56(1):33-40.
-
1996: Eron J J; Gilliam B; Fiscus S; Dyer J; Cohen M S
HIV-1 shedding and chlamydial urethritis.
JAMA : the journal of the American Medical Association 1996;275(1):36.
-
1995: Eron J J; Benoit S L; Jemsek J; MacArthur R D; Santana J; Quinn J B; Kuritzkes D R; Fallon M A; Rubin M
Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter. North American HIV Working Party.
The New England journal of medicine 1995;333(25):1662-9.
-
1995: Pogue R R; Eron J; Frelinger J A; Matsui M
Amino-terminal alteration of the HLA-A*0201-restricted human immunodeficiency virus pol peptide increases complex stability and in vitro immunogenicity.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(18):8166-70.
-
1994: Vernazza P L; Eron J J; Cohen M S; van der Horst C M; Troiani L; Fiscus S A
Detection and biologic characterization of infectious HIV-1 in semen of seropositive men.
AIDS (London, England) 1994;8(9):1325-9.
-
1994: Zhang D; Caliendo A M; Eron J J; DeVore K M; Kaplan J C; Hirsch M S; D'Aquila R T
Resistance to 2',3'-dideoxycytidine conferred by a mutation in codon 65 of the human immunodeficiency virus type 1 reverse transcriptase.
Antimicrobial agents and chemotherapy 1994;38(2):282-7.
-
1993: Vernazza P L; Eron J J; Fiscus S A
Loss of infectivity ex vivo in plasma of human immunodeficiency virus-infected patients correlates with a high CD4 cell count.
The Journal of infectious diseases 1993;168(5):1269-72.
-
1993: Campbell T B; Young R K; Eron J J; D'Aquila R T; Tarpley W G; Kuritzkes D R
Inhibition of human immunodeficiency virus type 1 replication in vitro by the bisheteroarylpiperazine atevirdine (U-87201E) in combination with zidovudine or didanosine.
The Journal of infectious diseases 1993;168(2):318-26.
-
1993: Eron J J; Chow Y K; Caliendo A M; Videler J; Devore K M; Cooley T P; Liebman H A; Kaplan J C; Hirsch M S; D'Aquila R T
pol mutations conferring zidovudine and didanosine resistance with different effects in vitro yield multiply resistant human immunodeficiency virus type 1 isolates in vivo.
Antimicrobial agents and chemotherapy 1993;37(7):1480-7.
-
1993: Chow Y K; Hirsch M S; Merrill D P; Bechtel L J; Eron J J; Kaplan J C; D'Aquila R T
Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapy.
Nature 1993;361(6413):650-4.
-
1992: Eron J J; Johnson V A; Merrill D P; Chou T C; Hirsch M S
Synergistic inhibition of replication of human immunodeficiency virus type 1, including that of a zidovudine-resistant isolate, by zidovudine and 2',3'-dideoxycytidine in vitro.
Antimicrobial agents and chemotherapy 1992;36(7):1559-62.
-
1992: Eron J J; Gorczyca P; Kaplan J C; D'Aquila R T
Susceptibility testing by polymerase chain reaction DNA quantitation: a method to measure drug resistance of human immunodeficiency virus type 1 isolates.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(8):3241-5.
-
1991: Johnson V A; Merrill D P; Videler J A; Chou T C; Byington R E; Eron J J; D'Aquila R T; Hirsch M S
Two-drug combinations of zidovudine, didanosine, and recombinant interferon-alpha A inhibit replication of zidovudine-resistant human immunodeficiency virus type 1 synergistically in vitro.
The Journal of infectious diseases 1991;164(4):646-55.
-
1991: D'Aquila R T; Bechtel L J; Videler J A; Eron J J; Gorczyca P; Kaplan J C
Maximizing sensitivity and specificity of PCR by pre-amplification heating.
Nucleic acids research 1991;19(13):3749.
-
1990: Eron J J; Hirsch M S
New anti-HIV-1 therapies and combinations: current data and prospects.
AIDS (London, England) 1990;4 Suppl 1():S193-200.
Sign-in to see more
